144 related articles for article (PubMed ID: 27176741)
1. Insights into K-Ras 4B regulation by post-translational lysine acetylation.
Knyphausen P; Lang F; Baldus L; Extra A; Lammers M
Biol Chem; 2016 Oct; 397(10):1071-85. PubMed ID: 27176741
[TBL] [Abstract][Full Text] [Related]
2. Allosteric Regulation of Switch-II Domain Controls KRAS Oncogenicity.
Yang MH; Tran TH; Hunt B; Agnor R; Johnson CW; Shui B; Waybright TJ; Nowak JA; Stephen AG; Simanshu DK; Haigis KM
Cancer Res; 2023 Oct; 83(19):3176-3183. PubMed ID: 37556505
[TBL] [Abstract][Full Text] [Related]
3. A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation.
Yin G; Kistler S; George SD; Kuhlmann N; Garvey L; Huynh M; Bagni RK; Lammers M; Der CJ; Campbell SL
J Biol Chem; 2017 Mar; 292(11):4446-4456. PubMed ID: 28154176
[TBL] [Abstract][Full Text] [Related]
4. Monitoring Ras Interactions with the Nucleotide Exchange Factor Son of Sevenless (Sos) Using Site-specific NMR Reporter Signals and Intrinsic Fluorescence.
Vo U; Vajpai N; Flavell L; Bobby R; Breeze AL; Embrey KJ; Golovanov AP
J Biol Chem; 2016 Jan; 291(4):1703-1718. PubMed ID: 26565026
[TBL] [Abstract][Full Text] [Related]
5. Molecular assemblies of the catalytic domain of SOS with KRas and oncogenic mutants.
Moghadamchargari Z; Shirzadeh M; Liu C; Schrecke S; Packianathan C; Russell DH; Zhao M; Laganowsky A
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723061
[TBL] [Abstract][Full Text] [Related]
6. Polylysine domain of K-ras 4B protein is crucial for malignant transformation.
Jackson JH; Li JW; Buss JE; Der CJ; Cochrane CG
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12730-4. PubMed ID: 7809111
[TBL] [Abstract][Full Text] [Related]
7. Prenylation of Ras proteins is required for efficient hSOS1-promoted guanine nucleotide exchange.
Porfiri E; Evans T; Chardin P; Hancock JF
J Biol Chem; 1994 Sep; 269(36):22672-7. PubMed ID: 8077219
[TBL] [Abstract][Full Text] [Related]
8. The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B.
Lu S; Jang H; Nussinov R; Zhang J
Sci Rep; 2016 Feb; 6():21949. PubMed ID: 26902995
[TBL] [Abstract][Full Text] [Related]
9. HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS.
Yang MH; Laurent G; Bause AS; Spang R; German N; Haigis MC; Haigis KM
Mol Cancer Res; 2013 Sep; 11(9):1072-7. PubMed ID: 23723075
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
[TBL] [Abstract][Full Text] [Related]
11. Regulation of RAS oncogenicity by acetylation.
Yang MH; Nickerson S; Kim ET; Liot C; Laurent G; Spang R; Philips MR; Shan Y; Shaw DE; Bar-Sagi D; Haigis MC; Haigis KM
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10843-8. PubMed ID: 22711838
[TBL] [Abstract][Full Text] [Related]
12. Structural and Mechanistic Insights into the Regulation of the Fundamental Rho Regulator RhoGDIα by Lysine Acetylation.
Kuhlmann N; Wroblowski S; Knyphausen P; de Boor S; Brenig J; Zienert AY; Meyer-Teschendorf K; Praefcke GJK; Nolte H; Krüger M; Schacherl M; Baumann U; James LC; Chin JW; Lammers M
J Biol Chem; 2016 Mar; 291(11):5484-5499. PubMed ID: 26719334
[TBL] [Abstract][Full Text] [Related]
13. NMR
Sharma AK; Lee SJ; Rigby AC; Townson SA
Biomol NMR Assign; 2018 Oct; 12(2):269-272. PubMed ID: 29721757
[TBL] [Abstract][Full Text] [Related]
14. Differences in flexibility underlie functional differences in the Ras activators son of sevenless and Ras guanine nucleotide releasing factor 1.
Freedman TS; Sondermann H; Kuchment O; Friedland GD; Kortemme T; Kuriyan J
Structure; 2009 Jan; 17(1):41-53. PubMed ID: 19141281
[TBL] [Abstract][Full Text] [Related]
15. Structural insight into the rearrangement of the switch I region in GTP-bound G12A K-Ras.
Xu S; Long BN; Boris GH; Chen A; Ni S; Kennedy MA
Acta Crystallogr D Struct Biol; 2017 Dec; 73(Pt 12):970-984. PubMed ID: 29199977
[TBL] [Abstract][Full Text] [Related]
16. Distinct dynamics and interaction patterns in H- and K-Ras oncogenic P-loop mutants.
Sayyed-Ahmad A; Prakash P; Gorfe AA
Proteins; 2017 Sep; 85(9):1618-1632. PubMed ID: 28498561
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics analysis of the structures of ras-guanine nucleotide exchange protein (SOS) bound to wild-type and oncogenic ras-p21. Identification of effector domains of SOS.
Chen JM; Friedman FK; Hyde MJ; Monaco R; Pincus MR
J Protein Chem; 1999 Nov; 18(8):867-74. PubMed ID: 10839623
[TBL] [Abstract][Full Text] [Related]
18. Biophysical Characterization of RAS-SOS Complexes by Native Mass Spectrometry.
Yun S; Scott E; Laganowsky A
Methods Mol Biol; 2024; 2797():177-193. PubMed ID: 38570460
[TBL] [Abstract][Full Text] [Related]
19. Lysine-acetylation as a fundamental regulator of Ran function: Implications for signaling of proteins of the Ras-superfamily.
Knyphausen P; Kuhlmann N; de Boor S; Lammers M
Small GTPases; 2015 Oct; 6(4):189-95. PubMed ID: 26507377
[TBL] [Abstract][Full Text] [Related]
20. SIRT2 and lysine fatty acylation regulate the transforming activity of K-Ras4a.
Jing H; Zhang X; Wisner SA; Chen X; Spiegelman NA; Linder ME; Lin H
Elife; 2017 Dec; 6():. PubMed ID: 29239724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
